Literature DB >> 19165455

[Palliative therapy in bronchial carcinoma--implanted delivery system and ports].

Thomas Reif-Gintl1, Wilfried Ilias.   

Abstract

This case report of a 54-year-old patient, with a metastasized non-small cell bronchial carcinoma, shows us the different ways in pain therapy alternatives. We report the possibility of using spinal delivery systems (especially epidural/intrathecal) in palliative therapy, if like in this case oral applicated opioids were not very successful. We discuss the advantages and disadvantages of this method and point out the possible side effects. Finally, we conclude that it has to be decided on a case per case basis, if this therapy is applicable or not.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19165455     DOI: 10.1007/s10354-008-0625-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  10 in total

Review 1.  [Diagnosis and therapy of lung neoplasms. Interdisciplinary guidelines].

Authors: 
Journal:  Wien Klin Wochenschr       Date:  2005       Impact factor: 1.704

Review 2.  [Continuous spinal analgesia in home care of oncologic pain].

Authors:  V Ricci; A Dalpane; E Lolli
Journal:  Minerva Med       Date:  1995-10       Impact factor: 4.806

3.  A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain.

Authors:  K A Nelson; P A Glare; D Walsh; E S Groh
Journal:  J Pain Symptom Manage       Date:  1997-05       Impact factor: 3.612

4.  Long-Term Spinal Opioid Therapy in Terminally Ill Cancer Pain Patients.

Authors: 
Journal:  Oncologist       Date:  1997

5.  Intrathecal infusional therapies for intractable pain: patient management guidelines.

Authors:  E S Krames
Journal:  J Pain Symptom Manage       Date:  1993-01       Impact factor: 3.612

6.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

Authors:  Rodrigo Arriagada; Bengt Bergman; Ariane Dunant; Thierry Le Chevalier; Jean-Pierre Pignon; Johan Vansteenkiste
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

7.  Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.

Authors:  M Sjöberg; P Nitescu; L Appelgren; I Curelaru
Journal:  Anesthesiology       Date:  1994-02       Impact factor: 7.892

Review 8.  Lung cancer in Europe in 2000: epidemiology, prevention, and early detection.

Authors:  Jerzy E Tyczynski; Freddie Bray; D Maxwell Parkin
Journal:  Lancet Oncol       Date:  2003-01       Impact factor: 41.316

Review 9.  Problems of long-term spinal opioid treatment in advanced cancer patients.

Authors:  Sebastiano Mercadante
Journal:  Pain       Date:  1999-01       Impact factor: 6.961

10.  Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience.

Authors:  H Samuelsson; F Malmberg; M Eriksson; T Hedner
Journal:  J Pain Symptom Manage       Date:  1995-02       Impact factor: 3.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.